Kong B - Search Results

1

Nrf2 expression in endometrial serous carcinomas and its precancers.

Chen N, Yi X, Abushahin N, Pang S, Zhang D, Kong B, Zheng W. Chen N, et al. Among authors: kong b. Int J Clin Exp Pathol. 2010 Dec 24;4(1):85-96. Int J Clin Exp Pathol. 2010. PMID: 21228930 Free PMC article.

2

Endometrial glandular dysplasia with frequent p53 gene mutation: a genetic evidence supporting its precancer nature for endometrial serous carcinoma.

Jia L, Liu Y, Yi X, Miron A, Crum CP, Kong B, Zheng W. Jia L, et al. Among authors: kong b. Clin Cancer Res. 2008 Apr 15;14(8):2263-9. doi: 10.1158/1078-0432.CCR-07-4837. Epub 2008 Mar 27. Clin Cancer Res. 2008. PMID: 18369088

3

Molecular identification of "latent precancers" for endometrial serous carcinoma in benign-appearing endometrium.

Zhang X, Liang SX, Jia L, Chen N, Fadare O, Schwartz PE, Kong B, Zheng W. Zhang X, et al. Among authors: kong b. Am J Pathol. 2009 Jun;174(6):2000-6. doi: 10.2353/ajpath.2009.081085. Epub 2009 May 12. Am J Pathol. 2009. PMID: 19435786 Free PMC article.

4

Personal history of breast cancer as a significant risk factor for endometrial serous carcinoma in women aged 55 years old or younger.

Liang SX, Pearl M, Liang S, Xiang L, Jia L, Yang B, Fadare O, Schwartz PE, Chambers SK, Kong B, Zheng W. Liang SX, et al. Among authors: kong b. Int J Cancer. 2011 Feb 15;128(4):763-70. doi: 10.1002/ijc.25395. Int J Cancer. 2011. PMID: 20473885

5

High levels of Nrf2 determine chemoresistance in type II endometrial cancer.

Jiang T, Chen N, Zhao F, Wang XJ, Kong B, Zheng W, Zhang DD. Jiang T, et al. Among authors: kong b. Cancer Res. 2010 Jul 1;70(13):5486-96. doi: 10.1158/0008-5472.CAN-10-0713. Epub 2010 Jun 8. Cancer Res. 2010. PMID: 20530669 Free PMC article.

6

A proposed model for endometrial serous carcinogenesis.

Zheng W, Xiang L, Fadare O, Kong B. Zheng W, et al. Among authors: kong b. Am J Surg Pathol. 2011 Jan;35(1):e1-e14. doi: 10.1097/PAS.0b013e318202772e. Am J Surg Pathol. 2011. PMID: 21164282 Review.

7

[Opinions about diagnosis and treatment of cervical cancer and its precancerous lesions in China].

Kong BH, Zheng W. Kong BH, et al. Zhonghua Yi Xue Za Zhi. 2010 Nov 23;90(43):3027-30. Zhonghua Yi Xue Za Zhi. 2010. PMID: 21211319 Chinese. No abstract available.

8

Prohibitin as a novel target protein of luteinizing hormone in ovarian epithelial carcinogenesis.

Jia L, Yi XF, Zhang ZB, Zhuang ZP, Li J, Chambers SK, Kong BH, Zheng W. Jia L, et al. Among authors: kong bh. Neoplasma. 2011;58(2):104-9. doi: 10.4149/neo_2011_02_104. Neoplasma. 2011. PMID: 21275458

9

Tubal origin of 'ovarian' low-grade serous carcinoma.

Li J, Abushahin N, Pang S, Xiang L, Chambers SK, Fadare O, Kong B, Zheng W. Li J, et al. Among authors: kong b. Mod Pathol. 2011 Nov;24(11):1488-99. doi: 10.1038/modpathol.2011.106. Epub 2011 Jun 24. Mod Pathol. 2011. PMID: 21701538 Free article.

10

Reduced CMTM5 expression correlates with carcinogenesis in human epithelial ovarian cancer.

Li P, Liu K, Li L, Yang M, Gao W, Feng J, Lv Y, Qu X, Kong B. Li P, et al. Among authors: kong b. Int J Gynecol Cancer. 2011 Oct;21(7):1248-55. doi: 10.1097/IGC.0b013e3182259c31. Int J Gynecol Cancer. 2011. PMID: 21841490

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,706 results

Search Page

Filters